Characterization of relevant kinases and phosphatases provides not only a new understanding of SMN function, but also constitutes a novel strategy for combinatorial therapeutic approaches to increase the level of SMN in SMA. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.